ConductScience.org, home

Paper29018174

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.

Kristensen SL and 14 others. Circ Heart Fail, 2017. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Papers, record 29018174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29018174

Download JSON
Disease
heart failure311 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
PubMed
Journal
Circ Heart Fail
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2021-12-04
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kristensen SLSøren Lund
2Jhund PSPardeep S
3Mogensen UMUlrik M
4Rørth RRasmus
5Abraham WTWilliam T
6Desai AAkshay
7Dickstein KKenneth
8Rouleau JLJean L
9Zile MRMichael R
10Swedberg KKarl
11Packer MMilton
12Solomon SDScott D
13Køber LLars
14McMurray JJVJohn J V
15PARADIGM-HF and ATMOSPHERE Committees and InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Atrial FibrillationMajor topic
Cardiovascular DiseasesMajor topic
Heart FailureMajor topic
HospitalizationMajor topic
Natriuretic Peptide, BrainMajor topic
Peptide FragmentsMajor topic
Aged
Amides
Aminobutyrates
Angiotensin Receptor Antagonists
Antihypertensive Agents
Biphenyl Compounds
Case-Control Studies
Cohort Studies
Drug Combinations
Enalapril
Female
Fumarates
Humans
Male
Middle Aged
Prognosis
Stroke Volume
Tetrazoles
Valsartan

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00853658Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureDerived from the trialYesClinicalTrials.gov
NCT01035255This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureDerived from the trialYesClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in29018175Lessons Learned and to Be Learned About the Use of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure and Atrial Fibrillation.https://conductscience.org/library/papers/29018175

Source PubMed

Download CSV of comments and corrections

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42650951Myocardial Function Assessment After Cardioversion in Persistent Atrial Fibrillation: Current Evidence and Future Directions.Diagnostics (Basel)2026https://conductscience.org/library/papers/42650951PubMed
41711708Atrial fibrillation increases left and right atrial pressures in patients with chronic heart diseases.ESC Heart Fail2026https://conductscience.org/library/papers/41711708PubMed
41209853
N‑Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) as a Biomarker in Heart Failure With Preserved Ejection Fraction (HFpEF) Versus Heart Failure With Reduced Ejection Fraction (HFrEF): The Way Forward in the Age of Proteomics.
Cureus2025https://conductscience.org/library/papers/41209853PubMed
40865190Prognostic Implications of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide Dynamics in Patients Undergoing Cardiac Surgery.JACC Adv2025https://conductscience.org/library/papers/40865190PubMed
40726817Left Atrial Remodeling Parameters and Brain Natriuretic Peptide Levels in Nonvalvular Atrial Fibrillation.J Saudi Heart Assoc2025https://conductscience.org/library/papers/40726817PubMed
40519716Comparison of Natriuretic Peptide Levels in Sinus Rhythm and Atrial Fibrillation in Acute Heart Failure.Int J Heart Fail2025https://conductscience.org/library/papers/40519716PubMed
40091615The addition of alpha-ketoglutarate to NT-proBNP improves the prediction of long-term all-cause mortality in acute heart failure patients.Ann Med2025https://conductscience.org/library/papers/40091615PubMed
40066216Prognostic Value of B-Type Natriuretic Peptide Level in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction.Circ Rep2025https://conductscience.org/library/papers/40066216PubMed
39139790A bibliometric analysis of light chain amyloidosis from 2005 to 2024: research trends and hot spots.Front Med (Lausanne)2024https://conductscience.org/library/papers/39139790PubMed
39129426Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis.Ann Med2024https://conductscience.org/library/papers/39129426PubMed
39076854Trace Elements Open a New Direction for the Diagnosis of Atherosclerosis.Rev Cardiovasc Med2023https://conductscience.org/library/papers/39076854PubMed
38939808FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis.JACC Adv2024https://conductscience.org/library/papers/38939808PubMed
38115625N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with worsening heart failure events.ESC Heart Fail2024https://conductscience.org/library/papers/38115625PubMed
37168845Prevalence and Correlates of Elevated NT-proBNP in Pregnant Women in the General U.S. Population.JACC Adv2023https://conductscience.org/library/papers/37168845PubMed
37084113Echocardiographic phenotype for refined risk stratification and treatment selection in light chain amyloidosis with heart failure.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37084113PubMed
36926939Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.J Am Heart Assoc2023https://conductscience.org/library/papers/36926939PubMed
36614172The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation.Int J Mol Sci2022https://conductscience.org/library/papers/36614172PubMed
36543554Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study.Br J Gen Pract2023https://conductscience.org/library/papers/36543554PubMed
35112889Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death.J Am Heart Assoc2022https://conductscience.org/library/papers/35112889PubMed
35079000Coding and regulatory variants are associated with serum protein levels and disease.Nat Commun2022https://conductscience.org/library/papers/35079000PubMed

See all 38 cited byDownload CSV of cited by

Drugs4

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
VALSARTANCHEMBL1069Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1069ChEMBL
ALISKIRENCHEMBL1639Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1639ChEMBL
SACUBITRILCHEMBL3137301Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3137301ChEMBL
ENALAPRILCHEMBL578Derived from the trial1https://conductscience.org/library/drugs/CHEMBL578ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29018174

GET https://conductscience.org/api/papers/v1/29018174/cited_by?page=2